Food and Drug Administration endorses coronavirus booster shots for children less than a week after Florida Surgeon General advises against males aged 18 to 39 from receiving mRNA jabs.
On October 7, Florida Surgeon General Dr. Joseph Ladapo issued guidance for mRNA COVID-19 vaccines, stating that with "a high level of global immunity to COVID-19, the benefit of vaccination is likely outweighed by this abnormally high risk of cardiac-related death among men" in the 18-39 age group.
The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.
The U.S. Food and Drug Administration’s (FDA) top vaccine official told a congressional committee on Friday that COVID-19 vaccines for kids under 6 will not have to meet the agency’s 50% efficacy threshold required to obtain Emergency Use Authorization (EUA).
Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.
